FCG Investment Company’s Bristol-Myers Squibb BMY Stock Holding History

FCG Investment Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.99M	Buy	34,461 +26,082	+311%	+$1.5M	0.69%	39
2026 Q1	$508K	Buy	+8,379	New	+$488K	0.22%	75
2025 Q3	$609K	Buy	13,493 +3,471	+35%	+$162K	0.28%	65
2025 Q2	$464K	Sell	10,022 -530	-5%	-$26K	0.24%	76
2025 Q1	$644K	Buy	+10,552	New	+$615K	0.4%	62
2024 Q2	–	Sell	-8,212	Closed	-$445K	–	94
2024 Q1	$445K	Buy	+8,212	New	+$418K	0.36%	78

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

FCG Investment Company's BMY Position: Q2 2026 in Review

FCG Investment Company increased its Bristol-Myers Squibb (BMY) stake by 311% in Q2 2026, buying an estimated $1.5M and bringing the position to 34,461 shares worth $1.99M. The position accounts for 0.69% of the portfolio, ranked #39.

FCG Investment Company first reported a position in BMY in Q1 2024 and has held it in 6 quarters since. 1,099 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

FCG Investment Company held 34,461 shares of Bristol-Myers Squibb worth $1.99M as of Q2 2026.
FCG Investment Company bought 26,082 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.5M.
Bristol-Myers Squibb made up 0.69% of FCG Investment Company's portfolio in Q2 2026, its #39 holding.
FCG Investment Company first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 6 quarters since.
1,099 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on FCG Investment Company's 13F filing for Q2 2026, filed 13 Jul 2026.